What is Blepharoplasty?
Blepharoplasty is an eyelid surgery used to treat droopy eyelids. It is majorly used for facial rejuvenation with direct aesthetic relation to the brow and the cheek. It is used to remove excess skin and/or orbital fat from upper and lower eyelids. According to the American Society of Plastic Surgery statistics for Cosmetic Plastic Surgery, the total number of cosmetic surgical procedures performed in 2018 was 17,721,671 of which around 206,529 are blepharoplasty surgeries. The number of females was the highest in the blepharoplasty surgeries accounting for 175,035 and the age group 55 and over is the highest contributor to the market. Blepharoplasty helps to improve the appearance and function of the upper and/or lower eyelids making the person look much younger than before, due to this advantage these surgeries are widely taken by adults above 40 years of age group. Blepharoplasty repositions and/or removes the excess skin and soft tissue from the eyelids to make them look more beautiful.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
High Growth Market | Asia Pacific |
Largest Market | North America |
Unit | Value (USD Billion) |
Key Companies Profiled | Advance Medical Systems Inc. (United States), Grand Aespio Inc. (South Korea), GTG Wellness Sdn. Bhd (Malaysia), USA Plastic Surgery (United States), London Bridge Plastic Surgery (United Kingdom), Montenegro Clinic of Plastic Surgery (Montenegro), Re-Aesthetic Limited (Hong Kong) and ThermiGen LLC (United States) |
CAGR | 5.97% |
The study covers a detailed analysis segmented by key business segments i.e. , by application (Skin, Muscle, or Fat Excision and Skin, Muscle, or Fat Repositioning) and major geographies. Research Analyst at AMA predicts that United States and European Players will contribute to the maximum growth of Global Blepharoplasty market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Blepharoplasty market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Advance Medical Systems Inc. (United States), Grand Aespio Inc. (South Korea), GTG Wellness Sdn. Bhd (Malaysia), USA Plastic Surgery (United States), London Bridge Plastic Surgery (United Kingdom), Montenegro Clinic of Plastic Surgery (Montenegro), Re-Aesthetic Limited (Hong Kong) and ThermiGen LLC (United States).
Market Overview:
In October 2020, Allergan Aesthetics, an AbbVie company, entered into an agreement with Luminera, a privately held, aesthetics company with a portfolio and pipeline of dermal filler products. The collaboration will expand the company's line of dermal fillers in the US and international markets. and August 2020: Merz Pharma Group acquired Aesthetics Science, Inc., a provider of aesthetic treatments.
In the United States, the regulatory body for blepharoplasty is the Food and Drug Administration (FDA). The FDA regulates medical devices, including surgical instruments used in blepharoplasty, and ensures that they are safe and effective for their intended use.
Blepharoplasty surgery providers are continuously focusing on development and adopting technological advancements. Such developments coupled with competitive pricing are likely to assist in increasing market share over the forecast period.
Influencing Trend:
Increasing Number of Aesthetic Surgeries in Asian Countries
Market Growth Drivers:
Growing Adoption of Anti-Aging Treatments and Rising Healthcare Expenditure To Enhance Personal Aesthetic Looks
Challenges:
Risk of Bleeding, Bruising, and Infection
Restraints:
High Cost of Blepharoplasty Surgeries
Opportunities:
Increasing Awareness Regarding Cosmetic Surgeries and Increasing Demand for Blepharoplasty Surgeries by Females
Key highlights of the Global Blepharoplasty market Study:
CAGR of the market during the forecast period 2022-2028
In-depth information on growth factors that will accelerate the Blepharoplasty market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Blepharoplasty market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Blepharoplasty Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blepharoplasty market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Blepharoplasty market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Blepharoplasty Providers, Government Regulatory and Research Organizations and Hospitals and Cosmetic Surgery Clinics.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.